Market Context
Mega-cap tech is showing signs of fatigue as Apple and Microsoft face headwinds. Meanwhile, USDCAD remains in a bullish trend despite an overbought RSI, and Bitcoin eyes a potential relief bounce. We break down the setups ahead of tomorrow’s US CPI print and the Bank of Canada decision.
Newsletter – June 09, 2026
Market Overview
The mega-cap technology sector is displaying clear signs of exhaustion as heavy regulatory headwinds and valuation skepticism temper recent optimism
[1]. Apple is bearing the brunt of this shift, hit by a double-whammy of EU regulatory setbacks that have delayed its AI rollout and growing Wall Street skepticism regarding the timeline for its iPhone upgrade cycle
[2][3]. At the same time, Microsoft has faced selling pressure despite locking in major public and private sector enterprise adoptions
[4][5], suggesting that high valuations are currently being met with a sell-on-the-news attitude across the board
[6]. Away from equities, the FX space…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Key Levels & Market Scenarios
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque.
Disclaimer
TradingNews24 provides market analysis and educational information only.
This article is not financial advice. Trading involves substantial risk of loss
and market analysis can be wrong. Past performance is not indicative of future results.
Always conduct your own research before making any trading decision.
See our Risk Disclosure,
Methodology, and
Editorial Policy.
Comments
No comments yet. Be the first!